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ABSTRACT
The Aspergillus fumigatus mouse model of asthma mimics the characteristics of human fungal asthma,
including local and systemic inflammation. Monocyte/macrophage lineage cells direct innate immune
responses and guide adaptive responses. To identify gene expression changes in peripheral blood mono-
cytes in the context of fungal allergy, mice were exposed to systemic and intranasal inoculations of fungal
antigen (sensitized), and naı̈ve and sensitized animals were challenged intratracheally with live A. fumi-
gatus conidia. Microarray analysis of blood monocytes from allergic versus non-allergic mice showed
≥ twofold modulation of 45 genes. Ingenuity pathway analysis revealed a network of these genes in-
volved in antigen presentation, inflammation, and immune cell trafficking. These data show that allergen
sensitization and challenge affects gene expression in peripheral monocytes.
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Environmental exposure to Aspergillus fungal species may
elicit a number of pulmonary diseases in humans, includ-
ing allergic asthma. Mold sensitivities often complicate
clinical asthma presentation, increasing the need for med-
ication in asthmatic children and the number of hospital
stays in patients 16–60 years of age (1–5). Allergic asthma
is a multifaceted syndrome consisting of airway hyper-
responsiveness, immune cell trafficking, airway obstruc-
tion, and tissue remodeling. Fungal sensitization is linked
to asthma severity, although the basis for this increased
pathology remains ambiguous. The Aspergillus fumigatus
mouse model of fungal allergic asthma is a useful tool
for studying pulmonary immune responses in vivo, as it
has been previously demonstrated to mimic many of the
pulmonary immune responses typical of human allergic
asthmatics, including local and systemic inflammation,
Correspondence
Jane M. Schuh, NDSU, Dept 7690, PO Box 6050, Fargo, ND, 58108-6050, USA.
Tel: 701-231-7841; fax: 701-231-9692; email: jane.schuh@ndsu.edu
Received 9 March 2010; revised 11 May 2010; accepted 3 June 2010.
List of Abbreviations: AM, alveolar macrophage; CV, coefficient of variation; FITC, fluorescein isothiocyanate; Ig, immunoglobulin; MACS, magnetic
cell sorting.
chronic pulmonary eosinophilia, elevated IgE levels, gob-
let cell hyperplasia, and peribronchial fibrosis (6, 7). This
model uses live fungal spores to challenge an animal that
has been sensitized to the soluble fungal antigen, allowing
a protracted course of study.
Previous research of gene expression changes in mono-
cytes and macrophages in response to Aspergillus conidia
has focused on time points immediately after direct, acute
exposure, examining the innate response to the fungus.
These studies have been carried out using primary human
monocytes, human monocyte cell lines, or mouse AM
cultured in vitro with A. fumigatus (8–12). Other groups
have carried out gene expression profiling on whole lung
tissue from an ovalbumin model for acute and chronic
asthma (13–15). While providing insight into the gene
expression changes occurring after A. fumigatus exposure
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in vitro or in the whole lung after ovalbumin in vivo,
none of these studies carried out transcriptional profil-
ing of monocytes in an in vivo chronic allergic model in
which the Aspergillus antigen is seen multiple times. As
cells of the monocyte/macrophage cell lineage not only
phagocytose fungal spores in the innate response, but also
inform the inflammatory and adaptive immune response,
we tested the hypothesis that systemic sensitization af-
fects gene regulation in peripheral blood monocytes that
may impact the pathogenesis of subsequent allergic pul-
monary responses. We used the A. fumigatus model of al-
lergic asthma to obtain an immunologically relevant gene
expression profile from peripheral blood monocytes and
compared them to cells from normal mice that had been
challenged with the allergen without sensitization.
Figure 1 depicts the experimental protocol used to iso-
late the peripheral blood monocytes from allergic and
Fig. 1. Schematic of the experimental design. Five mice in the
naı̈ve/challenged (N/C, control protocol) or sensitized/challenged (S/C,
allergy protocol) group were treated following the time course shown
above. Live A. fumigatus conidia were delivered intranasally or intratra-
cheally in the allergy protocol, whereas the control group received the
challenge only. Whole blood was collected, CCR3+ cells were removed
by MACS, and 30 000 F4/80+ FACS purified cells from each group were
sent to Miltenyi Biotec (Auburn, CA) for microarray analysis. Flow cy-
tometry and cytospin analysis of the CCR3−, F4/80+ population using
anti-F4/80-PE and anti-CCR3-FITC is shown. RNA was isolated from both
N/C and S/C blood monocyte samples and amplified using Miltenyi’s pro-
prietary SuperAmp amplification protocol, and was labeled with Cy5 and
Cy3, respectively. Samples were then hybridized to a PIQOR Immunology
Microarray (Miltenyi Biotec) containing 1076 genes in quadruplicate.
non-allergic mice used in the present study. All animal
studies were conducted with prior approval from the
North Dakota State University Institutional Animal Care
and Use Committee, which sets best practice standards
for the university under the guidance of the Office of Lab-
oratory Animal Welfare. BALB/c mice were used for the
chronic allergic asthma model and the treatment protocols
were carried out as previously described (6). Briefly, mice
treated with the allergy protocol were given intraperitoneal
(IP) and subcutaneous (SQ) injections of 10 μg soluble
A. fumigatus antigens in incomplete Freund’s adjuvant
(Sigma, St Louis, MO) for systemic sensitization. In weeks
3, 4, and 5, a 20 μl intranasal sensitization of 20 μg of
the same soluble antigen dissolved in normal saline was
given to localize the reaction to the airways. In week 6, a
challenge with 5 × 106 live A. fumigatus conidia was given
intratracheally in 30 μl PBS containing 0.1% Tween 80.
Control mice received the live spore challenge only. Three
days post-challenge, peripheral blood was collected, and
red blood cells were lysed. As previous experiments had
shown that F4/80+ cells from the blood of mice con-
sisted predominantly of monocytes and eosinophils, the
resulting cells were Fc blocked and stained with FITC anti-
CCR3 (R&D Systems, Minneapolis, MN). Magnetic bead-
conjugated anti-FITC antibodies (Miltenyi Biotec, Glad-
bach, Germany) were used to deplete CCR3+ eosinophils
from the populations by MACS. F4/80+ cells were puri-
fied by FACS from the resulting CCR3− population using
an anti-F4/80-PE antibody (eBioscience, San Diego, CA).
The CCR3−, F4/80+ cells were analyzed and sorted on a
FACSCalibur Flow Cytometer (BD Biosciences, San Jose,
CA). An aliquot of these cells was cytospun onto a glass
slide and stained with Quik-Dip differential stain (Mer-
cedes Medical, Sarasota, FL) to assess purity. Morphol-
ogy and staining verified the cell population to be >95%
monocytes.
Frozen cell pellets containing 30 000 CCR3−, F4/80+
peripheral blood monocytes from allergic mice or 30 000
CCR3−, F4/80+ peripheral blood monocytes from non-
allergic mice were sent to Miltenyi Biotec for microar-
ray analysis. Cell pellets were lysed using SuperAmp Lysis
buffer and SuperAmp RNA amplification was carried out
according to Miltenyi Biotec’s proprietary procedure. Ap-
proximately 2 μg cDNA was generated from each sample,
and the integrity of the samples was analyzed via the Agi-
lent Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Two hundred and fifty nanograms of each cDNA sample
was used for Cy3 or Cy5 labeling and both were hybridized
to a mouse PIQOR Immunology Microarray containing
1076 genes representing pathways involved in the areas of
apoptosis, signal transduction, stress, CD antigens, cell cy-
cle, DNA repair, chemokines, chemokine receptors, com-
plement system, cytokines, cytokine receptors, cytokine
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signaling and regulation, extracellular matrix proteins,
and inflammation. Fluorescence signals were detected us-
ing an Agilent Microarray Scanner system (Agilent Tech-
nologies). Ratios of gene expression changes obtained and
the CV among the quadruplicate features are reported in
Table 1 and are divided into functional groups. Forty-
five gene expression changes were detected that showed at
least a twofold change. Ten genes were upregulated and
35 genes were downregulated in allergic blood monocytes
versus non-allergic blood monocytes.
An Excel file containing gene names and fold changes
was uploaded to the Ingenuity Pathway Analysis (IPA)
website as previously described (16). Briefly, the Inge-
nuity Knowledge Base contains information from scien-
tific publications regarding direct and indirect relation-
ships between genes and proteins (17). A network was
constructed that contains 17 focus genes (those identi-
fied by our microarray analysis) and 17 non-focus genes,
which was optimized for high degrees of interconnectiv-
ity. Figure 2 shows the network of genes modulated in
peripheral blood monocytes in a chronic allergic asthma
model. IPA also categorizes modulated genes into bio-
logical process categories. Genes involved in major func-
tional areas were identified and included: immune cell
trafficking/cell movement: Foxo4, Ccl4, Gadd45a (a mem-
ber of the GADD45 stress sensor gene family), Cx3cr1,
Itgb4, Bax, Spock1, Ptpn12, Nrp1, Cd83, Cd63; antigen pre-
sentation: Il1r2, Ccl4, Map3k7, Cd83, Cx3cr1, Bax, Tap1,
Cd63; cell-mediated immune response: Foxo4, Cd83, Bax,
Cx3cr1, Tap1, Cd63, Ptpn12, Il1r2, Ccl4, Znf287, Gadd45a,
Map3k7, Prkch, Itgb4, Spock1, Nrp1; and the inflammatory
response: Il1r2, Ccl4,Map3k7, Cd83, Cx3cr1, Bax, Tap1,
and Cd63.
Fungal spores are ubiquitous in the environment. When
they are inhaled into the airway of a normal, non-
sensitized individual, they are eliminated by AM with-
out an exaggerated inflammatory response. However, in
an individual who has been sensitized to these allergens,
the inhalation of fungal spores elicits a number of imme-
diate and ongoing immune responses, including a frank
inflammatory response. To better understand the effect
of sensitization on monocyte function in the allergic im-
mune response, we analyzed the gene expression of blood
monocytes from allergic animals that had been challenged
with spores from the allergenic fungus A. fumigatus and
compared them with non-allergic animals that had also
been exposed to fungal spores.
Several genes that were modulated in these experiments
have been identified as important to the interaction of the
host cell and the fungus in other similar microarray stud-
ies, although the direction of the modulation was not
always consistent between our chronic in vivo model and
the in vitro examinations. For example, although the up-
regulation of Egr1, Ifng, CD83 and Icam1 that we observed
was not tested or did not reach significance in similar mi-
croarray studies, there was overlap with at least one of the
other studies in the upregulation of these genes. In con-
trast, however, members of the Gadd45 family, Cflar and
Icam1 were modestly upregulated in murine AMs after
co-culture with conidia, whereas our results showed a de-
crease in their transcription (12) and our study of murine
blood monocytes from allergic animals did not show many
of the changes revealed by direct co-incubation of the host
cell and fungi (8, 9, 12). We believe this to be a reflection of
the activation state of the allergen-sensitized mice and of
the fact that the monocytes do not encounter the particu-
late fungal conidia until reaching the lung, thus different
parameters are being measured.
We have previously highlighted the importance of var-
ious chemokines and their receptors in this disease state
and have shown that both an inflammatory and an aller-
gic, Th2-mediated response are observed after exposure
to fungus (18–22). Classically activated macrophages re-
spond to interferon (IFN)-γ to produce a number of in-
flammatory mediators and chemokines, including CCL3
and CCL4. Indeed, after direct exposure to fungus in pri-
mary human monocytes from healthy subjects, a human
monocytic cell line and murine AM, these chemokine
genes were upregulated, reflecting an inflammatory re-
sponse against the fungus (8, 9, 11, 12). The present study
marks the first time that the genetic expression patterns
of peripheral blood monocytes have been explored in an
allergic animal. Refuting the hypothesis that monocytes
may enter the allergic lung from the blood already ex-
pressing an alternative activation pattern, we found that
allergic sensitization did not skew the monocyte lineage
to the pro-allergy alternative activation pattern, but did
exacerbate the inflammatory capacity of the cells in the
blood with Ifng and Il1r2 expression being upregulated in
conjunction with the chemokines Ccl3 and Ccl4. Interest-
ingly, these same four genes (Ifng, Il1r2, Ccl3, and Ccl4)
that were upregulated in monocytes from allergic animals
were expressed prominently in a human monocyte cell
line that was co-cultured with A. fumigatus hyphae and
treated with voriconizole, an anti-fungal medication (11).
Again, this represents a strong, protective inflammatory
response in these antigen-exposed animals, which con-
tradicts the idea that allergic sensitization is an aberrant
immune response.
The IPA investigation of the data revealed several inter-
actions between focus genes, including Cd63-Itgb4-Bax,
CD83-Prkch and Foxo4-Gadd45. All of these genes have
been associated with cellular proliferation. Regarding the
Cd63-Itgb4-Bax relationship, Cd63 and integrin beta 4
proteins have been shown to bind to each other on the
plasma membrane (23), and integrin beta 4 signaling
560 c© 2010 The Societies and Blackwell Publishing Asia Pty Ltd
Allergic blood monocyte characterization
Table 1. Genes modulated in allergic vs non-allergic PBM
Fold change/CV
Adhesion
ICAM1: intercellular adhesion molecule 1 −4.12/29%
CLEC4A2: C-type lectin domain family 4 member A, CLEC4A −2.05/4%
ITGA4: integrin alpha-4, VLA-4 −2.35/6%
ITGB4: integrin beta-4 −4.66/102%
LAMA3: laminin alpha-3 chain −2.10/73%
Apoptosis, intracellular proteins, signal transduction and stress
ATF5: activating transcription factor 5, ATFX 2.12/35%
BAX: apoptosis regulator BAX 2.17/4%
CFLAR: CASP8 and FADD-like apoptosis regulator precursor, CLARP, MRIT, CASH −6.83/46%
EGR1: early growth response protein 1, ZNF225 2.5/16%
FOXO4: forkhead box protein O4, AFX1, AFX, MLLT7 −2.06/46%
GADD45: growth arrest and DNA-damage-inducible protein, DDIT1, GADD45 −2.61/96%
IGFBP1: insulin-like growth factor binding protein 1 −2.07/36%
MADD: map kinase-activating death domain protein −4.40/46%
MAP3K4: mitogen-activated protein kinase kinase kinase 4, MTK1 −2.30/2%
MAP3K7: mitogen-activated protein kinase kinase kinase 7, TAK1 −2.46/48%
MAP3K8: mitogen-activated protein kinase kinase kinase 9, COT, TPL2 −5.42/9%
MAPK8IP1: C-jun-amino-terminal kinase interacting protein 1, JIP1, IB1 −2.37/13%
MAPK9: mitogen-activated protein kinase 9, PRKMP, JNK2 −2.15/0%
MLL3: myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog, HALR −2.48/41%
PREPL: prolyl endopeptidase-like 2.17/8%
PRKCH: protein kinase C, ETA, PKCL −2.18/27%
PTPN12: protein-tyrosine phosphatase G1 −2.82/18%
SKAT2: zinc finger protein SKAT2 −2.06/47%
TAP1: antigen peptide transporter 1, ABCB2, PSF1, RING4, Y3, MTP1, HAM-1 −2.03/58%
CD antigens and cell surface receptors
CD45: leukocyte common antigen, PTPTC, LY-5 −2.03/4%
CD63: CD63 antigen, LAMP-3, granulophysin 3.22/7%
CD83: CD83 antigen, HB15, BL11 −3.05/78%
CD94: CD94 antigen, KLRD1 −2.68/46%
NRP1: neuropilin-1, VEGF165R −2.21/6%
Cell cycle and DNA repair
TOPBP1: DNA topoisomerase II binding protein 1 −4.16/45%
Chemokines and chemokine receptors
CCL3: macrophage inflammatory protein 1-ALPHA, MIP1A, SCYA4 2.17/8%
CCL4: macrophage inflammatory protein 1-BETA, MIP1B, SCYA4 3.03/8%
CX3CR1: CX3C chemokine receptor 1, GPR13 −4.96/3%
Cytokines and cytokine receptors
ACVR1: activin receptor type I −3.98/69%
IFNG: interferon gamma 2.56/8%
IL1R2: interleukin-1 receptor, type II, IL1RB 2.04/4%
IL1RAPL2: interleukin-1 receptor accessory protein-like 2, IL1R9 2.22/17%
TNFRSF21: tumor necrosis factor receptor superfamily member 21, DR6 −3.35/21%
Cytokine signaling, secretion and regulation
AMSH: STAM-associated protein, STAMBP −2.16/48%
CBP: cytohesin binding protein HE, PSCDBP −2.29/11%
IL18BP: interleukin-18 binding protein −11.12/102%
NFATX: nuclear factor of activated T-cells, cytoplasmic 3, NFAT3C, NFAT4 −2.25/23%
SOCS6: suppressor of cytokine signaling 6, SOCS4, CIS4 −2.04/5%
STX3A: syntaxin 3 −2.26/65%
Extracellular matrix proteins
SPOCK1: TESTICAN-1, TIC1, TICN1 −5.23/61%
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Fig. 2. IPA network analysis of molecule interactions. The microar-
ray expression value changes were uploaded to the Ingenuity Pathway
Analysis website and were analyzed by their proprietary software. The
IPA Network Generation Algorithm created a network containing 17
‘focus genes’ that were shown to be differentially expressed between
the naı̈ve and sensitized groups and are indicated by asterisks. An addi-
tional 17 intermediate molecules called ‘non-focus genes’ were placed
in the network by the Ingenuity software. Whereas the gene expression
levels of the non-focus genes were not shown to be changed by the mi-
croarray analysis, they have been previously shown to interact with the
focus genes indentified in this study. Symbols representing functional
categories of the molecules are listed in the legend.
has been shown to upregulate Bax (24). CD83 and pro-
tein kinase C eta are related, as the addition of a PKC
inhibitor blocked phosphatidic acid and tumor necrosis
factor-alpha induced CD83 surface expression (25). Last,
the Foxo4 and Gadd45 relationship has been established
in that Foxo4, a forkhead transcription factor, has been
shown to bind to the Gadd45 promoter and modulate
its transcription to influence G2/M cell cycle arrest (26).
These interactions, demonstrated in the IPA network, en-
hance our knowledge regarding the relationships of gene
expression changes in peripheral blood monocytes in al-
lergic fungal asthma.
In conclusion, the present study presents significant
findings confirming in vivo changes in the expression
of several genes in peripheral monocytes including Egr1,
Ccl3, Ccl4, Gadd45, Cflar and Icam1, which were observed
in previous acute exposure A. fumigatus-induced allergic
asthma studies. These data also support the supposition
that sensitization has global systemic effects on innate
immune cells which affect local inflammatory responses
and may change the host’s response to environmental ex-
posures. The novel targets we discovered and the rela-
tionships highlighted by IPA will provide direction for
additional studies with the ultimate hope of providing
more useful drug targets to aid the amelioration of aller-
gic asthma.
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